Login to Your Account

Biopharma Credit's $762M IPO highlights flexible funding needs

By Nuala Moran
Staff Writer

Thursday, March 30, 2017

LONDON – Biopharma Credit plc has become the first fund specializing in debt finance for life sciences to list on the London Stock Exchange (LSE), after raising $762 million in an IPO.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription